ArticleMedicine2026
Use of the blood urea nitrogen level to predict the rebleeding in patients with non-variceal upper gastrointestinal bleeding.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prognostic Value of BUN-Based Ratios for Mortality and Prolonged Hospitalization in Acute Upper Gastrointestinal Bleeding: Comparison with Established Risk Scores.Medicina (Kaunas, Lithuania) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The blood urea nitrogen (BUN) and blood urea nitrogen-to-creatinine ratio (BCR) are elevated in patients with upper gastrointestinal bleeding (UGIB). If bleeding persists after an initial endoscopic hemostasis, BUN levels will remain elevated or continue to increase. When identifying the occurrence of rebleeding is difficult, clinicians should perform second-look endoscopy, which is costly and invasive. This study aimed to evaluate whether changes in the BCR or BUN levels aid in determining rebleeding in patients with UGIB. Two hundred eleven patients underwent an initial and follow-up endoscopy within 72 hours for non-variceal UGIB at Chungbuk National University Hospital (Cheongju, Korea). We evaluated the changes in the BCR and BUN levels, based on the presence of rebleeding within 72 hours of the initial endoscopy. Twenty-five (11.8%) patients had rebleeding at the follow-up endoscopy within 72 hours after the initial endoscopy. The overall initial BCR was 38.3 ± 16.0 (median: 35.8). The BCR difference at follow-up endoscopy was 14.1 ± 14.5 in the no-rebleeding group and 4.5 ± 13.2 in the rebleeding group (P = .004). The optimal cutoff value of the BCR difference to predict rebleeding was 8.8. The changes in the BUN level at the follow-up endoscopy were 14.4 ± 12.3 mg/dL in the no-rebleeding group and 5.4 ± 9.5 mg/dL in the rebleeding group (P = .001). The optimal cutoff value of the BUN difference that predicted rebleeding was 7.5 mg/dL. Multivariate analysis revealed that older patients tended to have more rebleeding (P = .034). BCR and BUN level changes may aid in determining whether rebleeding has occurred, thereby preventing unnecessary second-look endoscopy in patients with UGIB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.